chr13-39655733-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020751.3(COG6):āc.7G>Cā(p.Glu3Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000245 in 1,594,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 34)
Exomes š: 0.000025 ( 0 hom. )
Consequence
COG6
NM_020751.3 missense
NM_020751.3 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 4.60
Genes affected
COG6 (HGNC:18621): (component of oligomeric golgi complex 6) This gene encodes a subunit of the conserved oligomeric Golgi complex that is required for maintaining normal structure and activity of the Golgi apparatus. The encoded protein is organized with conserved oligomeric Golgi complex components 5, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07668218).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG6 | NM_020751.3 | c.7G>C | p.Glu3Gln | missense_variant | 1/19 | ENST00000455146.8 | NP_065802.1 | |
COG6 | NM_001145079.2 | c.7G>C | p.Glu3Gln | missense_variant | 1/19 | NP_001138551.1 | ||
COG6 | XM_011535168.2 | c.7G>C | p.Glu3Gln | missense_variant | 1/20 | XP_011533470.1 | ||
COG6 | NR_026745.1 | n.107G>C | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COG6 | ENST00000455146.8 | c.7G>C | p.Glu3Gln | missense_variant | 1/19 | 1 | NM_020751.3 | ENSP00000397441 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152250Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
3
AN:
152250
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000462 AC: 1AN: 216360Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 117944
GnomAD3 exomes
AF:
AC:
1
AN:
216360
Hom.:
AF XY:
AC XY:
0
AN XY:
117944
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000250 AC: 36AN: 1442574Hom.: 0 Cov.: 40 AF XY: 0.0000237 AC XY: 17AN XY: 715922
GnomAD4 exome
AF:
AC:
36
AN:
1442574
Hom.:
Cov.:
40
AF XY:
AC XY:
17
AN XY:
715922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152368Hom.: 0 Cov.: 34 AF XY: 0.0000268 AC XY: 2AN XY: 74514
GnomAD4 genome
AF:
AC:
3
AN:
152368
Hom.:
Cov.:
34
AF XY:
AC XY:
2
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2024 | The c.7G>C (p.E3Q) alteration is located in exon 1 (coding exon 1) of the COG6 gene. This alteration results from a G to C substitution at nucleotide position 7, causing the glutamic acid (E) at amino acid position 3 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Benign
D;D;.
Sift4G
Benign
T;T;T
Polyphen
0.0010
.;B;.
Vest4
MutPred
Gain of catalytic residue at E7 (P = 0.0484);Gain of catalytic residue at E7 (P = 0.0484);Gain of catalytic residue at E7 (P = 0.0484);
MVP
MPC
0.058
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at